V. Gopalakrishnan et al. (Gopalakrishnan et al., 2018) reported that melanoma patients who responded to anti-PD-1 blockade had high abundance of Faecalibacterium species, and this population had longer PFS and higher levels of effector CD4+ and CD8+ T cells in systemic circulation. The gene discussed is PDCD1; the disease is melanoma.